|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,983.50 GBX | +1.72% |
|
+3.15% | +8.71% |
| 09:07am | Cooler PCE, Hotter Chips |  |
| 08:00am | Bernstein: GSK Poised for Sustainable Growth Amid 'Much More Durable' HIV Franchise; Price Target, Forecasts Up | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 102B | |||||
| 996B | |||||
| 580B | |||||
| 415B | |||||
| 326B | |||||
| 280B |
- Stock Market
- Stocks
- GSK Stock
- Charts GSK plc
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
